Smallpox was once a common, deadly disease, that killed a third of those who contracted it. 200 years ago, it was discovered that vaccination could prevent smallpox. Learn more about the fight against smallpox in our videos
Smallpox was once a common, deadly disease, that killed a third of those who contracted it. 200 years ago, it was discovered that vaccination could prevent smallpox. Learn more about the fight against smallpox in our video (turn on subtitles in your language)!
Rabies is a deadly disease and endemic in over 100 countries. It causes around 59,000 human deaths annually, the vast majority in Asia and Africa. There are safe and effective human vaccines for pre- and post-exposure prophylaxis. With a prompt and proper post-exposure prophylaxis (PEP), exposed people have a survival rate close to 100%.
Shigellosis is a relatively uncommon disease in the European Union/European Economic Area (EU/EEA), but remains of concern in some countries and for some population groups. For 2017, 30 EU/EEA countries reported 6 337 confirmed shigellosis cases.
ECDC coordinates the enhanced surveillance for hepatitis A, B and C to help countries define epidemiological trends or transmission patterns among newly diagnosed cases.
World Hepatitis Day on 28 July provides an opportunity each year to increase the awareness and understanding of viral hepatitis.
Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed. This is a major obstacle on the way towards the Sustainable Development Goal (SDG) for health in 2030 as highlighted by ECDC on occasion of World Hepatitis Day.
For 2018, 30 EU/EEA Member States reported 24 588 cases of hepatitis B virus (HBV) infection. When the five countries that only reported acute cases are excluded, the number of cases is 24 034, which corresponds to a crude rate of 6.0 cases per 100 000 population.
This report provides the first collation of data relating to the monitoring of the progress towards the elimination of hepatitis B and C for EU/EEA countries.
The first report monitoring the progress towards the elimination of hepatitis B and C across European Union (EU) and European Economic Area (EEA) countries has been published by ECDC.